This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In addition, MDisrupt will add new features to the marketplace platform through a strategic collaboration with the Association to meet the needs of its members, providing new ways for them to engage with the healthtechnology, health services, medical device, and life sciences sectors. MDisrupt has raised $6.6
This pilot study represents a critical step in leveraging digital healthtechnology to enhance cancer treatment outcomes,” said John Wagner, M.D., The study, led by principal investigator Nitin Ohri, M.D., Chief Medical Officer, Koneksa. “By
Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions.
Beacon’s mobile EEG will join more than a dozen digital healthtechnologies that are already integrated into the Koneksa solution. About Koneksa Koneksa is a healthcaretechnology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy.
As the digital health sector continues to grow, Scotland is well-positioned to play a leading role in shaping the future of healthcare. Corporate Development for HealthcareTechnology companies in EMEA HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Nelson Advisors HealthcareTechnology > Mergers, Acquisitions, Growth, Strategy, Investments [link] We work with HealthcareTechnology founders, owners and investors to assess whether they should 'Build, Buy, Partner, Invest or Sell' in order to maximise shareholder value and investment returns.
Mergers, Acquisitions, Growth and Strategy for HealthcareTechnology companies in EMEA HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Dialogue HealthTechnologies: A provider of virtual care services for chronic conditions.
Nelson Advisors work with HealthcareTechnology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content